Press Releases News / Events Overview Press Releases In The News IR Calendar Email Alerts Year All Years 2021 2020 2019 Category All Releases Financial Releases NeuBase Therapeutics to Present at the BTIG Virtual Biotechnology Conference on Tuesday, August 11th Jul 30, 2020 4:01pm EDT NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer Jul 28, 2020 8:00am EDT NeuBase Therapeutics Added to Russell 3000® and Russell Microcap® Indexes Jun 29, 2020 9:00am EDT NeuBase Therapeutics Reports Financial Results for the Second Fiscal Quarter of 2020 May 14, 2020 4:05pm EDT NeuBase Therapeutics to Present at Upcoming Investor Conferences in May 2020 May 11, 2020 8:00am EDT NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 30, 2020 4:05pm EDT NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock Apr 28, 2020 9:44am EDT NeuBase Therapeutics Announces Proposed Public Offering of Common Stock Apr 27, 2020 4:01pm EDT NeuBase Therapeutics Announces Positive, Preclinical Data Validating its Novel Genetic Therapy PATrOL™ Platform Mar 31, 2020 7:00am EDT NeuBase Therapeutics Reports Financial Results for the First Fiscal Quarter of 2020 Mar 26, 2020 4:05pm EDT Prev 1 2 3 4 5 6 Next
NeuBase Therapeutics to Present at the BTIG Virtual Biotechnology Conference on Tuesday, August 11th Jul 30, 2020 4:01pm EDT
NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer Jul 28, 2020 8:00am EDT
NeuBase Therapeutics Reports Financial Results for the Second Fiscal Quarter of 2020 May 14, 2020 4:05pm EDT
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 30, 2020 4:05pm EDT
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock Apr 28, 2020 9:44am EDT
NeuBase Therapeutics Announces Positive, Preclinical Data Validating its Novel Genetic Therapy PATrOL™ Platform Mar 31, 2020 7:00am EDT
NeuBase Therapeutics Reports Financial Results for the First Fiscal Quarter of 2020 Mar 26, 2020 4:05pm EDT
